Citigroup Inc Biodesix Inc Transaction History
Citigroup Inc
- $190 Billion
- Q1 2025
A detailed history of Citigroup Inc transactions in Biodesix Inc stock. As of the latest transaction made, Citigroup Inc holds 4,654 shares of BDSX stock, worth $1,396. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,654
Previous 82,856
94.38%
Holding current value
$1,396
Previous $124,000
98.39%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding BDSX
# of Institutions
64Shares Held
51.1MCall Options Held
65.5KPut Options Held
500-
Telemark Asset Management, LLC Boston, MA8.28MShares$2.48 Million0.75% of portfolio
-
Bryn Mawr Trust CO Bryn Mawr, PA6.1MShares$1.83 Million0.07% of portfolio
-
Birchview Capital, LP Burlington, VT5.74MShares$1.72 Million3.25% of portfolio
-
Aigh Capital Management LLC Baltimore, MD4.27MShares$1.28 Million1.45% of portfolio
-
Silverarc Capital Management, LLC4.1MShares$1.23 Million0.63% of portfolio
About BIODESIX INC
- Ticker BDSX
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 39,982,000
- Market Cap $12M
- Description
- Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pat...